查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1722945

2025 年至 2033 年合成生物学市场规模、份额、趋势及预测（依产品、技术、应用及地区）

Synthetic Biology Market Size, Share, Trends and Forecast by Product, Technology, Application, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球合成生物学市场规模价值 185 亿美元。展望未来， IMARC Group估计到 2033 年市场规模将达到 667 亿美元，2025 年至 2033 年的复合年增长率为 15.3%。北美目前占据市场主导地位，到 2024 年市占率将超过 41.8%。北美的主导地位可以归因于强大的生物技术基础设施、对研究业务的不断增加的投资以及政府的支持措施。

合成生物学市场分析：

主要市场驱动因素：受基因编辑技术不断进步的推动，全球合成生物学市场正经历强劲成长。

主要市场趋势：学术界、工业界和政府之间的合作努力正在增强创新和发展能力。

地理趋势：由于对生物技术的投资不断增加，北美占据市场主导地位。然而，由于亚太地区研究活动和政府措施的不断增加，亚太地区正在成为一个快速成长的市场。

竞争格局：主要参与者正在投资研究业务以推动创新并应对复杂的生物挑战。合成生物学产业的主要市场参与者包括 GenScript Biotech Corporation、Amyris Inc.、Ginkgo Bioworks、Mammoth Biosciences、Novozymes、Merck KGaA 等。

挑战与机会：挑战包括与基因改造产品相关的道德和安全问题。儘管如此，市场可望开发符合法规、符合道德规范的创新机会来克服这些挑战。

合成生物学市场趋势/驱动因素：

基因编辑技术的进步

目前，CRISPR-Cas9 等各种技术能够透过精确且有效率地操纵遗传物质来改善生物学研究领域，从而增强合成生物学市场的需求。研究人员正在以极高的精度设计、编辑和改造 DNA 序列，从而促进根据特定功能定制的复杂合成生物的诞生。这项创新为新领域的发展开闢了新途径，例如透过基因疗法治疗疾病以及创造能够生产酶和生物燃料等有价值化合物的生物工程生物，从而有助于市场扩张。此外，世界卫生组织（WHO）发布了人类基因组编辑全球治理的开创性建议，强调安全性、有效性和道德性。

对永续解决方案的需求

各行各业对永续和环保解决方案的需求不断增长，推动了合成生物学市场的发展。合成生物学为各行各业提供了各种新途径来满足其减少营运对环境影响的需求。与此相符的是，从可再生资源中提取的生物塑胶的生产以及符合全球永续发展要求的减少碳排放的生物燃料的开发正在促进市场成长。除此之外，合成生物学能够创造微生物用于生物修復，这是一种去除污染物或帮助清洁环境并解决各种紧急生态问题的方法。此外，合成生物学正在彻底改变美容产业的永续发展努力。 Vogue Business 估计，每年有 20% 至 40% 的美容产品被废弃，该行业每年产生 1200 亿个难以回收的包装。此外，十分之八的化妆品成分都来自不可持续的来源。为了应对这些挑战，合成生物学会修改微生物 DNA 以创造永续材料。合成生物学市场价格因创新和多样化应用而呈现快速成长。

协作生态系统与投资

学术界、工业界和政府实体之间的协作协同作用为合成生物学领域的研究活动创造了有利的环境。合作促进了知识、资产和观点的交流，从而加快了发明的速度。管理当局经常提供补助金和资金来协助研究工作，而成熟企业和新创公司则共同努力，汇集资源用于促进市场成长的开创性计画。此外，创投对生物技术新创企业的投资激增，为该领域注入了重要的资本，促进了新兴创意成长为有形产品和合成生物学市场应用。这个协作生态系统维持研究、创新和商业化的循环，推动全球合成生物学市场向前发展。

此外，合成生物学市场的未来有望带来无与伦比的创新、永续性解决方案和广阔的成长潜力。 Algal Bio 等公司利用多种菌株来创新解决方案，而 Basecamp Research 等新创公司则采用机器学习 (ML) 来破解自然界的合成蛋白质工程设计原理。

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球合成生物学市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品

  • 寡核苷酸/寡核苷酸池和合成DNA
  • 酵素
  • 克隆技术试剂盒
  • 异种核酸
  • 底盘有机体

第七章：市场区隔：依技术

  • NGS技术
  • PCR技术
  • 基因组编辑技术
  • 生物加工技术
  • 其他的

第 8 章：市场区隔：按应用

  • 卫生保健
    • 关键部分
      • 临床
      • 非临床/研究
  • 非医疗保健
    • 关键部分
      • 生物技术作物
      • 特种化学品
      • 生物燃料
      • 其他的

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第十章：SWOT分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Agilent Technologies Inc.
    • Amyris Inc.
    • Codexis Inc.
    • Danaher Corporation
    • Eurofins Scientific
    • GenScript Biotech Corporation
    • Illumina Inc.
    • Merck KGaA
    • New England Biolabs
    • Synthego Corporation
    • Thermo Fisher Scientific Inc.
    • Twist Bioscience
    • Viridos Inc.
Product Code: SR112025A5534

The global synthetic biology market size was valued at USD 18.5 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 66.7 Billion by 2033, exhibiting a CAGR of 15.3% from 2025-2033. North America currently dominates the market, holding a market share of over 41.8% in 2024. The dominance of North America can be attributed to robust biotechnology infrastructure, increasing investments in research operations, and supportive government initiatives.

Synthetic Biology Market Analysis:

Major Market Drivers: The global synthetic biology market is experiencing robust growth, driven by increasing improvements in gene editing technologies.

Key Market Trends: Collaborative efforts between academia, industry, and government are enhancing innovation and development capabilities.

Geographical Trends: North America dominates the market owing to the growing investments in biotechnology. However, Asia Pacific is emerging as a fast-growing market due to the increasing research activities and government initiatives in the region.

Competitive Landscape: Key players are investing in research operations to drive innovation and address complex biological challenges. Some of the major market players in the synthetic biology industry include GenScript Biotech Corporation, Amyris Inc., Ginkgo Bioworks, Mammoth Biosciences, Novozymes, Merck KGaA, among many others.

Challenges and Opportunities: Challenges include ethical and safety concerns related to genetically modified products. Nonetheless, opportunities for the market to develop regulatory-compliant, ethically considered innovations are projected to overcome these challenges.

Synthetic Biology Market Trends/Drivers:

Advancements in gene editing technologies

At present, various techniques like CRISPR-Cas9 are capable of improving the field of biology research by enabling precise and efficient manipulation of genetic material, strengthening the synthetic biology market demand. Researchers are designing, editing, and engineering DNA sequences with exceptional accuracy, facilitating the creation of intricate synthetic organisms customized according to specific functions. This innovation is opening new avenues for the development of novel aspects, like disease treatment through gene therapies and creation of bioengineered organisms capable of producing valuable compounds such as enzymes and biofuels, thus aiding in market expansion. Moreover, The World Health Organization (WHO) released groundbreaking recommendations for the global governance of human genome editing, emphasizing safety, efficacy, and ethics.

Demand for sustainable solutions

The rising demand for sustainable and environment-friendly solutions across various industries is propelling the synthetic biology market. Synthetic biology presents various new avenues for sectors to fulfill their demands to reduce the environmental impact of their operations. In line with this, the production of bioplastics extracted from renewable resources and the development of biofuels with reduced carbon emissions aligning with the global push towards sustainability are contributing to the market growth. Apart from this, synthetic biology is capable of creating microbes for bioremediation which is a method to detoxify contaminants or help clean up the environment and address various urgent ecological complications. Furthermore, synthetic biology is revolutionizing the sustainability efforts of the beauty sector. Vogue Business estimates that 20-40% of beauty products become waste annually, and the industry generates 120 billion units of difficult-to-recycle packaging yearly. Moreover, eight out of ten cosmetic ingredients are unsustainably sourced. To address these challenges, synthetic biology modifies microorganism DNA to create sustainable materials. The synthetic biology market price reflects rapid growth due to innovation and diverse applications.

Collaborative ecosystem and investment

The collaborative synergy between academia, industry, and government entities fosters a conducive environment for research operations within the synthetic biology field. Collaborations facilitate the exchange of knowledge, assets, and perspectives, thus quickening the rate of invention. Governing authorities frequently provide grants and funds to assist research endeavors, while established businesses and startups work together to pool resources for ground-breaking ventures that promote market growth. In addition to this, the surge in venture capital investments in biotechnology startups injects vital capital into the field, nurturing the growth of nascent ideas into tangible products and synthetic biology market application. This collaborative ecosystem sustains a cycle of research, innovation, and commercialization, propelling the global synthetic biology market forward.

Additionally, the future of the synthetic biology market promises unparalleled innovation, sustainability solutions, and expansive growth potential. Companies, such as Algal Bio utilize a diverse array of strains to innovate novel solutions, while startups like Basecamp Research employ machine learning (ML) to decipher the design principles of nature for synthetic protein engineering.

Synthetic Biology Industry Segmentation:

Breakup by Product:

  • Oligonucleotide/Oligo Pools and Synthetic DNA
  • Enzymes
  • Cloning Technologies Kits
  • Xeno-nucleic Acids
  • Chassis Organism

Oligonucleotide/oligo pools and synthetic DNA dominates the market

The growing demand for synthetic biology products, specifically oligonucleotide/oligo pools and synthetic DNA, is mainly fueled by the exponential growth in fields such as personalized medicine, gene therapy, and molecular diagnostics that have amplified the need for precise and customizable genetic materials. Additionally, the rise of synthetic biology startups and the democratization of gene editing technologies have made these products more accessible, empowering researchers across diverse disciplines to engage in innovative projects, thereby creating a favorable synthetic biology market outlook. For example, Synbio Technologies offers oligo pool synthesis for companies or clients who need to mass-produce short DNA strands, also known as oligonucleotides.

Breakup by Technology:

  • NGS Technology
  • PCR Technology
  • Genome Editing Technology
  • Bioprocessing Technology
  • Others

Next-generation sequencing (NGS) technology has become instrumental in deciphering complex biological information, facilitating the analysis of vast genetic data sets, and accelerating the discovery of novel genetic components, which in turn, is presenting lucrative market opportunities. Moreover, polymerase chain reaction (PCR) technology remains a cornerstone for DNA amplification, crucial in generating sufficient genetic material for various applications, from research to diagnostics. Besides this, genome editing technologies, particularly CRISPR-Cas9, hold immense promise for precision genetic modifications, driving advancements in gene therapies and customized genetic engineering. Bioprocessing technologies form a critical facet, enabling efficient large-scale production of bioengineered compounds, ranging from pharmaceuticals to biofuels. Companies are also investing and focusing on these aspects to create novel technologies. For example, Bayer and Mammoth Biosciences collaborated to develop a novel gene editing technology to unlock the full potential of CRISPR systems.

Additionally, the synthetic biology market statistics highlight a robust growth trajectory, driven by advancements in biotechnology and increasing investment in research and development.

Breakup by Application:

  • Healthcare
  • Clinical
  • Non-Clinical/Research
  • Non-Healthcare
  • Biotech Crops
  • Specialty Chemicals
  • Bio-Fuels
  • Others

The bolstering growth of the healthcare sector, wherein synthetic biology is used in the development of personalized medicines, gene therapies, and diagnostics, is contributing to the synthetic biology market growth. In addition, the numerous non-clinical or research applications of synthetic biology encompassing drug discovery, functional genomics, and biomolecule production, are fueling scientific exploration and market growth. Beyond healthcare, synthetic biology's expanding usage in biotech crops engineered for improved yield and resistance to pests is positively influencing the market. Furthermore, the increasing product adoption across the specialty chemicals industry, wherein bioengineered pathways create sustainable routes to produce high-value compounds is impelling the market growth. Apart from this, the growing use of synthetic biology in the biofuel sector to optimize microorganisms for efficient biofuel production is strengthening the market growth. Key market players are focusing on collaborating with each other to develop various novel technologies in synthetic biology. For instance, scientists led by Gerard Wright at McMaster University developed a synthetic biology platform for novel glycopeptide antibiotics (GPA) discovery. They engineered Streptomyces coelicolor as a chassis for GPA biosynthesis, overcoming challenges in cloning large biosynthetic gene clusters (BGCs) using an optimized transformation-associated recombination (TAR) system. The platform enabled the synthesis of corbomycin and the discovery of novel GPAs, expanding antibiotic candidates' repertoire.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest synthetic biology market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The presence of a well-established research and innovation ecosystem in North America, characterized by leading academic institutions, cutting-edge biotechnology companies, and significant government investments, provides a fertile ground for advancements in synthetic biology. Moreover, the region's emphasis on R&D and technological innovation fosters collaborations that span academia and industry, driving the development of novel applications across sectors including healthcare, agriculture, and energy. In addition to this, the increasing focus on sustainable solutions and the demand for eco-friendly products align with synthetic biology's potential to offer greener alternatives. This, coupled with favorable regulatory frameworks that encourage biotechnology R&D, creates an environment conducive to the expansion of the North American synthetic biology market. In December 2022, the Investment Strategy by the Office of Strategic Capital (OSC) identifies synthetic biology as a priority technology area for private sector investment, aiming to attract capital and foster innovation in this field for national security purposes. The synthetic biology market overview reveals its rapid expansion, driven by innovation, research investment, and diverse applications.

Competitive Landscape:

The global synthetic biology market features a dynamic competitive landscape shaped by a blend of established players and innovative startups. Leading companies, with their significant financial resources and expansive research capabilities, dominate the market by offering a diverse range of synthetic biology products and services and highlighting how big is the synthetic biology market? These companies actively engage in collaborations, strategic partnerships, and mergers to enhance their offerings and expand their market reach. Furthermore, a surge in venture capital investments has catalyzed the emergence of agile startups, injecting fresh ideas and disruptive technologies into the field. The competitive arena is characterized by a focus on innovation, technology integration, and the ability to address diverse market segments, accentuating the evolutionary nature of the global synthetic biology market. On of the key players, Eurofins Genomics Blue Heron, introduced its IVT mRNA Synthesis Service, using cutting-edge technology for rapid and efficient mRNA transcript production. Tailored for various fields including molecular biology and gene therapy, it offers customizable synthesis with quick turnaround times and expert support, benefiting synthetic biology research and applications. According to synthetic biology market recent news, Aanika Biosciences is revolutionizing synthetic biology adoption across industries like food and agriculture through insurance. Their subsidiary, Aanika Insurance Services (AIS), offers cost-effective coverage, encouraging biologic use while ensuring risk mitigation and frequent sampling. Partnering with Western Growers Insurance Services, Aanika aims to expand its reach to farmers, distributors, and retailers.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Agilent Technologies Inc.
  • Amyris Inc.
  • Codexis Inc.
  • Danaher Corporation
  • Eurofins Scientific
  • GenScript Biotech Corporation
  • Illumina Inc.
  • Merck KGaA
  • New England Biolabs
  • Synthego Corporation
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience
  • Viridos Inc.

Key Questions Answered in This Report

  • 1.What is synthetic biology?
  • 2.How big is the synthetic biology market?
  • 3.What is the expected growth rate of the global synthetic biology market during 2025-2033?
  • 4.What are the key factors driving the global synthetic biology market?
  • 5.What is the leading segment of the global synthetic biology market based on product?
  • 6.What is the leading segment of the global synthetic biology market based on technology?
  • 7.What is the leading segment of the global synthetic biology market based on application?
  • 8.What are the key regions in the global synthetic biology market?
  • 9.Who are the key players/companies in the global synthetic biology market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Synthetic Biology Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Oligonucleotide/Oligo Pools and Synthetic DNA
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Enzymes
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Cloning Technologies Kits
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Xeno-nucleic Acids
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Chassis Organism
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 NGS Technology
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 PCR Technology
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Genome Editing Technology
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Bioprocessing Technology
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Healthcare
    • 8.1.1 Market Trends
    • 8.1.2 Key Segments
      • 8.1.2.1 Clinical
      • 8.1.2.2 Non-Clinical/Research
    • 8.1.3 Market Forecast
  • 8.2 Non-Healthcare
    • 8.2.1 Market Trends
    • 8.2.2 Key Segments
      • 8.2.2.1 Biotech Crops
      • 8.2.2.2 Specialty Chemicals
      • 8.2.2.3 Bio-Fuels
      • 8.2.2.4 Others
    • 8.2.3 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Agilent Technologies Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Amyris Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 Codexis Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Danaher Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Eurofins Scientific
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 GenScript Biotech Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Illumina Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Merck KGaA
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 New England Biolabs
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Synthego Corporation
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Twist Bioscience
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
    • 14.3.13 Viridos Inc.
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio

List of Figures

  • Figure 1: Global: Synthetic Biology Market: Major Drivers and Challenges
  • Figure 2: Global: Synthetic Biology Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Synthetic Biology Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Synthetic Biology Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Synthetic Biology Market: Breakup by Technology (in %), 2024
  • Figure 6: Global: Synthetic Biology Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Synthetic Biology Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Synthetic Biology (Oligonucleotide/Oligo Pools and Synthetic DNA) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Synthetic Biology (Oligonucleotide/Oligo Pools and Synthetic DNA) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Synthetic Biology (Enzymes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Synthetic Biology (Enzymes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Synthetic Biology (Cloning Technologies Kits) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Synthetic Biology (Cloning Technologies Kits) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Synthetic Biology (Xeno-nucleic Acids) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Synthetic Biology (Xeno-nucleic Acids) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Synthetic Biology (Chassis Organism) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Synthetic Biology (Chassis Organism) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Synthetic Biology (NGS Technology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Synthetic Biology (NGS Technology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Synthetic Biology (PCR Technology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Synthetic Biology (PCR Technology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Synthetic Biology (Genome Editing Technology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Synthetic Biology (Genome Editing Technology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Synthetic Biology (Bioprocessing Technology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Synthetic Biology (Bioprocessing Technology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Synthetic Biology (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Synthetic Biology (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Synthetic Biology (Healthcare) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Synthetic Biology (Healthcare) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Synthetic Biology (Non-Healthcare) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Synthetic Biology (Non-Healthcare) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: North America: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: North America: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: United States: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: United States: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Canada: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Canada: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Asia-Pacific: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Asia-Pacific: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: China: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: China: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Japan: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Japan: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: India: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: India: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: South Korea: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: South Korea: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Australia: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Australia: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Indonesia: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Indonesia: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Others: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Others: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Europe: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Europe: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Germany: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Germany: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: France: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: France: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: United Kingdom: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: United Kingdom: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Italy: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Italy: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Spain: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Spain: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Russia: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Russia: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Others: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Others: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Latin America: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Latin America: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Brazil: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Brazil: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Mexico: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Mexico: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Others: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Others: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Middle East and Africa: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Middle East and Africa: Synthetic Biology Market: Breakup by Country (in %), 2024
  • Figure 80: Middle East and Africa: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Global: Synthetic Biology Industry: SWOT Analysis
  • Figure 82: Global: Synthetic Biology Industry: Value Chain Analysis
  • Figure 83: Global: Synthetic Biology Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Synthetic Biology Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Synthetic Biology Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Synthetic Biology Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 4: Global: Synthetic Biology Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Synthetic Biology Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Synthetic Biology Market: Competitive Structure
  • Table 7: Global: Synthetic Biology Market: Key Players